Health Care & Life Sciences » Pharmaceuticals | Estechpharma Co. Ltd.

Estechpharma Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
42,247
44,215
45,066
43,397
38,214
Cost of Goods Sold (COGS) incl. D&A
29,632
35,820
37,175
32,419
27,877
Gross Income
12,616
8,394
7,891
10,978
10,337
SG&A Expense
5,998
8,444
7,313
8,176
7,658
EBIT
6,600
65
438
-
2,535
Unusual Expense
385
45
1,886
-
1,221
Non Operating Income/Expense
427
11,461
917
2,024
58
Interest Expense
1,625
1,101
982
269
224
Pretax Income
4,261
10,397
1,278
4,540
1,163
Income Tax
558
1,858
757
392
351
Equity in Affiliates
-
-
350
-
-
Consolidated Net Income
3,703
8,539
870
4,148
1,514
Net Income
3,703
8,539
870
4,148
1,514
Net Income After Extraordinaries
3,703
8,539
870
4,148
1,514
Net Income Available to Common
3,703
8,539
870
4,148
1,514
EPS (Basic)
359.00
795.00
80.00
369.00
132.00
Basic Shares Outstanding
10
11
11
11
11
EPS (Diluted)
340.98
792.15
79.83
349.19
130.21
Diluted Shares Outstanding
11
11
11
12
12
EBITDA
10,534
3,717
4,536
7,107
6,725
Other Operating Expense
18
15
139
26
144
Non-Operating Interest Income
98
147
167
11
97
Equity in Affiliates (Pretax)
-
-
-
63
-

About Estechpharma Co.

View Profile
Address
25 Barangongdan-ro
Hwaseong-si GY 18608
Korea, Republic Of
Employees -
Website http://www.estechpharma.com
Updated 09/14/2018
Estechpharma Co., Ltd. engages in the manufacture and supply of pharmaceutical ingredients and fine chemicals. Its products include treatment of alcoholism, anti-inflammatory, analgesics, muscle relaxant, antiseptic, antispasmodics, anti-cataracts, capillary protectant, unnatural amino acid, anti-hepatitis, anti-parkinsonian, antihistamine, nootropic and anti-diabetics. The company was founded on June 1, 1996 and is headquartered in Hwaseong-si, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.